制药、生物科技和生命科学行业A股上市公司S维度绩效对比分析:2024年度 vs 2023年度(上)
Jin Rong Jie·2026-01-30 02:27

Background - The concept of ESG (Environmental, Social, and Governance) is becoming mainstream, with a focus on the "S" (Social) dimension, emphasizing human-centric values and the expectations of various stakeholders [1] - The pharmaceutical, biotechnology, and life sciences industries play a crucial role in national economic development and social construction, making ESG governance a critical issue for these sectors [1] S (Social) Performance Analysis - As of May 5, 2025, 161 companies in the A-share pharmaceutical, biotechnology, and life sciences sector have disclosed their 2024 ESG reports, compared to 134 companies for 2023 [2] Employee Rights - Employee rights are central to the social dimension of ESG, impacting a company's ESG rating, financing ability, and long-term competitiveness [3] - Protecting employee rights enhances satisfaction, reduces turnover, and improves productivity, which can lead to higher ESG ratings and better brand image [3] Employee Structure Comparison - In 2024, the proportion of companies with female employees above 45% decreased by 36.35% compared to 2023, while those with female employee ratios between 20% and 45% increased by 38.29% [4] Senior Female Employee Proportion - The proportion of companies with senior female employees at 30% or above dropped by 44.50% in 2024 compared to 2023, indicating a lack of focus on gender equality and support for women's career advancement [4] Employment of Disabled Individuals - The percentage of companies employing disabled individuals decreased by 6.50% in 2024, reflecting insufficient long-term planning and support for this demographic [6][8] Employee Benefits - The proportion of companies providing complete paid leave benefits dropped by 30.82% in 2024, indicating a significant reduction in employee welfare amidst economic pressures [10] - In 2024, 31.68% of companies offered generous holiday benefits, a decrease of 46.27% from 2023 [13] Employee Health Management - In 2024, 49.07% of companies prioritized employee health management, an increase of 31.50% from 2023, indicating a growing recognition of health management as a fundamental ESG practice [15] Labor Rights - The percentage of companies with 100% labor contract signing and social insurance coverage increased by 9.84% in 2024, showing a heightened focus on labor rights protection [17] Employee Training and Development - In 2024, 31.68% of companies provided over 40 hours of training per employee, a 57.21% increase from 2023, reflecting a commitment to employee development [19] Social Responsibility - The industry saw a decline in charitable donations and participation in disaster relief in 2024 compared to 2023, indicating a shift away from "pseudo-charity" practices towards more sustainable social responsibility initiatives [20][23]

制药、生物科技和生命科学行业A股上市公司S维度绩效对比分析:2024年度 vs 2023年度(上) - Reportify